4WM
AZN icon

44 Wealth Management’s AstraZeneca AZN Stock Holding History

44 Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$534K Sell
2,817
-3,719
-57% -$700K 0.18% 131
2026
Q1 		$1.29M Sell
6,536
-68
-1% -$13.1K 0.45% 81
2025
Q4 		$1.21M Sell
6,604
-1,757
-21% -$308K 0.41% 87
2025
Q3 		$1.28M Buy
8,361
+62
+0.7% +$9.38K 0.44% 84
2025
Q2 		$1.16M Buy
8,299
+1,568
+23% +$220K 0.41% 82
2025
Q1 		$989K Buy
6,731
+1,206
+22% +$174K 0.37% 92
2024
Q4 		$724K Sell
5,525
-645
-10% -$90.3K 0.28% 103
2024
Q3 		$950K Buy
+6,170
New +$996K 0.33% 94
2023
Q2 		$912K Sell
6,368
-761
-11% -$112K 0.31% 76
2023
Q1 		$990K Sell
7,129
-2,217
-24% -$298K 0.33% 72
2022
Q4 		$1.27M Buy
9,346
+114
+1% +$14.3K 0.44% 60
2022
Q3 		$1.01M Sell
9,232
-412
-4% -$52.3K 0.42% 65
2022
Q2 		$1.27M Buy
9,644
+255
+3% +$33.5K 0.49% 53
2022
Q1 		$1.25M Buy
9,389
+114
+1% +$13.7K 0.45% 60
2021
Q4 		$1.08M Sell
9,275
-146
-2% -$17.2K 0.37% 67
2021
Q3 		$1.13M Sell
9,421
-95
-1% -$11.1K 0.43% 60
2021
Q2 		$1.14M Buy
9,516
+2,226
+31% +$244K 0.44% 58
2021
Q1 		$725K Buy
7,290
+2,498
+52% +$251K 0.3% 76
2020
Q4 		$479K Buy
+4,792
New +$508K 0.22% 99

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

44 Wealth Management's AZN Position: Q2 2026 in Review

44 Wealth Management reduced its AstraZeneca (AZN) stake by 57% in Q2 2026, selling an estimated $700K and leaving 2,817 shares worth $534K. The position accounts for 0.18% of the portfolio, ranked #131.

44 Wealth Management first reported a position in AZN in Q4 2020 and has held it in 19 quarters since. The position peaked at $1.29M in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • 44 Wealth Management held 2,817 shares of AstraZeneca worth $534K as of Q2 2026.
  • 44 Wealth Management sold 3,719 AstraZeneca shares in Q2 2026, an estimated $700K.
  • AstraZeneca made up 0.18% of 44 Wealth Management's portfolio in Q2 2026, its #131 holding.
  • 44 Wealth Management first reported a position in AstraZeneca in Q4 2020 and has held it in 19 quarters since.
  • 44 Wealth Management's AstraZeneca position peaked at $1.29M in Q1 2026.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on 44 Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.